1[1]Burakoff SJ, Deeg HJ, Ferrara, et al. Graft-versus-host disease: immunology, pathophysiology, and treatment[M]. New York.:Marcel Dekker, 1990.539-555.
2[2]Gale RP, Horowitz MM, Ash RC, et al.Identical-twin bone marrow transplants for leukemia[J]. Ann Intern Med,1994,120(8): 646-652.
3[3]Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors[J]. Transplantation,1974,18(4):295-304.
同被引文献4
1[3]Sanchez AR, Sheridan PJ, Rogers RS. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report[J]. J Periodontol,2004, 75 (4):613-619.
2Taylor AL,Gibbs P,Bradley JA.Acute graft versus host disease following liver transplantation:the enemy within[J].Am J Transplant,2004,4(4):466-474.
3Whalen JG,Jukic DM,English JC 3rd.Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation[J].J Am Acad Dermatol,2005,52(5):908-912.
4Merad M,Hoffmann P,Ranheim E,et al.Depletion of host Langerhans cells before transplantation of donor alloreactive T ceils prevents skin graft-versus-host disease[J].Nat Med,2004,10(5):510-517.
